Gilead Sciences
GILD
155.60
+2.53
+1.65%
Gilead Sciences
US · GILD
#110 by market cap
Listed 1992
155.60
+2.53
+1.65%
Live - 5344 symbols - heartbeat 411s ago
· 2026-10-20 10:49
Analyst consensus 19 analysts
Buy
Avg price target 163.28 +4.9%
Price target rangecurrent 155.60
Low130.00
Avg163.28
High177.00
Buy 89%
Hold 11%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-09 | UBS | -- | Buy | 175.00 |
| 2026-10-08 | Scotiabank | -- | Buy | 177.00 |
| 2026-10-07 | Truist Financial | -- | Buy | 158.00 |
| 2026-10-07 | Morgan Stanley | -- | Buy | 163.00 |
| 2026-10-07 | J.P. Morgan | -- | Buy | 170.00 |
| 2026-09-24 | UBS | -- | Buy | 175.00 |
| 2026-09-10 | HSBC | -- | Buy | 175.00 |
| 2026-09-07 | Bernstein | -- | Buy | 160.00 |
| 2026-08-31 | Mizuho Securities | -- | Buy | 170.00 |
| 2026-08-28 | Truist Financial | -- | Buy | -- |
| 2026-08-28 | Scotiabank | -- | Buy | 177.00 |
| 2026-08-27 | BMO Capital | -- | Buy | 174.00 |
| 2026-08-20 | Morgan Stanley | -- | Buy | 165.00 |
| 2026-08-17 | BMO Capital | -- | Buy | 174.00 |
| 2026-08-13 | Barclays | -- | Hold | 145.00 |
| 2026-08-06 | Maxim Group | -- | Buy | 165.00 |
| 2026-08-06 | BMO Capital | -- | Buy | 174.00 |
| 2026-08-06 | J.P. Morgan | -- | Buy | 160.00 |
| 2026-08-05 | Wells Fargo | -- | Buy | 165.00 |
| 2026-08-05 | BofA Securities | -- | Buy | 162.00 |
| 2026-08-05 | Truist Financial | -- | Buy | 150.00 |
| 2026-08-05 | Morgan Stanley | -- | Buy | 165.00 |
| 2026-08-05 | Evercore | -- | Buy | -- |
| 2026-08-05 | Needham | -- | Buy | 170.00 |
| 2026-08-04 | TD Cowen | -- | Buy | 160.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Buy
Analyst consensus
Buy
All 2 views agree: bullish.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Improving
2
■ Upgrades■ Downgrades
- 2 upgrades vs 0 downgrades among tracked analyst rating changes.
- Most recent: HSBC moved from Hold to Buy on 2026-07-06.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-07-06 | HSBC | Hold → Buy | 155.00 |
| 2026-05-20 | Maxim Group | Hold → Buy | 165.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-04 | After close | ±5.02% | -2.58% (in line) |
| 2026/Q1 | 2026-05-07 | After close | ±5.48% | -2.04% (in line) |
| 2025/Q4 | 2026-02-10 | After close | ±5.16% | +5.82% (beat) |
| 2025/Q3 | 2025-10-30 | After close | ±6.68% | +1.14% (in line) |
| 2025/Q2 | 2025-08-07 | After close | ±6.97% | +8.28% (beat) |
| 2025/Q1 | 2025-04-24 | After close | ±5.61% | -2.81% (in line) |
| 2024/Q4 | 2025-02-11 | -- | ±4.70% | +7.46% (beat) |
| 2024/Q3 | 2024-11-06 | After close | ±3.99% | +6.77% (beat) |
| 2024/Q2 | 2024-08-08 | After close | ±5.33% | -2.55% (in line) |
| 2024/Q1 | 2024-04-25 | After close | ±4.59% | +0.23% (in line) |
| 2023/Q4 | 2024-02-06 | After close | ±3.97% | -4.25% (beat) |
| 2023/Q3 | 2023-11-07 | After close | ±3.78% | -3.36% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-20 10:49:52 · For reference only, not investment advice and not tailored to your situation.
Gilead Sciences discussion 0 comments